Appendix 10. Matrix of study endpoints (part 3).
Character- istic |
Quan SL, 2008 | Tian X, 2007 | Wang DG 2003 | Wang WH, 2006 | Wang XL, 2004 | Xu CB, 2000 | Xu SG, 2002 | Zhang G, 2005 |
---|---|---|---|---|---|---|---|---|
Intervention (s)& control (s) |
I: Xuezhikang C: simvastatin |
I: Xiaozhiling (herb mixture) C: simvastatin |
I: Xuezhikang C: pravastatin |
I: Xuezhikang C: atorvas- tatin |
I: Xuezhikang C: simvastatin |
I: Xuezhikang C: pravastatin |
I: Xuezhikang C1: lovastatin |
I: Xuezhikang C: atorvas- tatin |
Primary1 endpoint(s) |
./. | ./. | ./. | ./. | ./. | ./. | ./. | ./. |
Secondary2 endpoint(s) |
./. | ./. | ./. | ./. | ./. | ./. | ./. | ./. |
Other3 end- point(s) |
TC, TG,HDL- C, LDL-C, liver func- tion, renal function, CK, blood sugar, blood and urine rou- tine check, and electrocar- diogram |
TC, TG, HDL- C, LDL-C, blood pres- sure, weight, nutrition, liver func- tion, renal function, electrocar- dio- gram, blood routine, urine rou- tine, stoop routine. |
TC, LDL- C, TG, HDL-C |
TC, HDL- C, LDL-C, liver function, renal func- tion, creatine, glucose, glucose, blood rou- tine, urine rou- tine, electro- cardiogram |
TC, HDL- C, LDL-C. |
TC, TG, HDL- C, LDL-C, LDL-C/ HDL-C(L/ H), and TC-HDL- C/HDL-C, ALT, ALP, AST, CPK, crea- tine kinase, BUN, blood glu- cose, routine blood, urine testing |
TC, TG, HDL- C, LDL-C, blood sugar, SGPT, CPK, blood and urine rou- tine check, physical ex- amine, and electrocar- diogram |
TC, TG, LDL-C, HDL-C, fasting glu- cose, blood urea nitrogen, ALT, elec- trocardio- gram, blood routine, creatine ki- nase, creati- nine. |
Footnotes
as stated in the publication
as stated in the publication
not stated as primary or secondary endpoint(s) in the publication
./.: not reported
ALT: alanine aminotransferase; BUN: urea nitrogen; C: control; CPK: creatine phosphokinase, HDL-C: high density lipoprotein cholesterol; I: intervention; LDL-C: low density lipoprotein cholesterol; TC: total cholesterol.